A detailed history of Pro Share Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 200,858 shares of BSX stock, worth $18.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
200,858
Previous 216,039 7.03%
Holding current value
$18.2 Million
Previous $16.6 Million 1.17%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $1.11 Million - $1.28 Million
-15,181 Reduced 7.03%
200,858 $16.8 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $1.11 Million - $1.28 Million
16,430 Added 8.23%
216,039 $16.6 Million
Q1 2024

May 08, 2024

SELL
$57.6 - $68.62 $300,614 - $358,127
-5,219 Reduced 2.55%
199,609 $13.7 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $964,920 - $1.15 Million
-19,838 Reduced 8.83%
204,828 $11.8 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $289,244 - $315,120
-5,763 Reduced 2.5%
224,666 $11.9 Million
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $447,579 - $491,869
9,002 Added 4.07%
230,429 $12.5 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $1.24 Million - $1.38 Million
27,488 Added 14.17%
221,427 $11.1 Million
Q4 2022

Feb 02, 2023

SELL
$39.56 - $47.22 $216,353 - $258,246
-5,469 Reduced 2.74%
193,939 $8.98 Million
Q3 2022

Nov 04, 2022

SELL
$36.71 - $109.66 $833,317 - $2.49 Million
-22,700 Reduced 10.22%
199,408 $7.72 Million
Q2 2022

Aug 01, 2022

SELL
$35.24 - $47.1 $2.99 Million - $3.99 Million
-84,707 Reduced 27.61%
222,108 $8.28 Million
Q1 2022

May 10, 2022

SELL
$40.9 - $45.1 $351,740 - $387,860
-8,600 Reduced 2.73%
306,815 $13.6 Million
Q4 2021

Feb 08, 2022

BUY
$38.07 - $44.87 $2.66 Million - $3.14 Million
69,892 Added 28.47%
315,415 $13.4 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $14,430 - $16,058
350 Added 0.14%
245,523 $10.7 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $1.57 Million - $1.8 Million
40,583 Added 19.84%
245,173 $10.5 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $330,656 - $371,906
-9,375 Reduced 4.38%
204,590 $7.91 Million
Q4 2020

Feb 09, 2021

BUY
$33.15 - $41.97 $626,568 - $793,274
18,901 Added 9.69%
213,965 $7.69 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $740,046 - $907,438
-21,488 Reduced 9.92%
195,064 $7.45 Million
Q2 2020

Aug 03, 2020

BUY
$30.19 - $39.11 $34,265 - $44,389
1,135 Added 0.53%
216,552 $7.6 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $1.17 Million - $2.06 Million
-45,131 Reduced 17.32%
215,417 $7.03 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $1.29 Million - $1.54 Million
33,951 Added 14.98%
260,548 $11.8 Million
Q3 2019

Nov 12, 2019

BUY
$40.31 - $43.45 $404,430 - $435,933
10,033 Added 4.63%
226,597 $9.22 Million
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $1.21 Million - $1.49 Million
-34,672 Reduced 13.8%
216,564 $9.31 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $298,493 - $369,602
9,070 Added 3.75%
251,236 $9.64 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $333,514 - $410,349
10,511 Added 4.54%
242,166 $8.56 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $578,070 - $680,197
-17,608 Reduced 7.06%
231,655 $8.92 Million
Q2 2018

Aug 13, 2018

SELL
$26.84 - $34.32 $351,979 - $450,072
-13,114 Reduced 5.0%
249,263 $8.15 Million
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $221,457 - $250,809
8,788 Added 3.47%
262,377 $7.17 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $2.44 Million - $2.94 Million
98,613 Added 63.63%
253,589 $6.29 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $582,972 - $647,574
22,200 Added 16.72%
154,976 $4.52 Million
Q2 2017

Aug 11, 2017

BUY
N/A
132,776
132,776 $3.68 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.